Response to Ryan and Parwani: heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?

作者信息

Bozkurt Biykem

机构信息

Section of Cardiology, Michael E. DeBakey VA Medical Center & Winters Center for Heart Failure Research, Baylor College of Medicine, Houston, TX, USA.

出版信息

Circ Heart Fail. 2012 Nov;5(6):820-1. doi: 10.1161/CIRCHEARTFAILURE.112.972240.

DOI:10.1161/CIRCHEARTFAILURE.112.972240

PMID:23170022

Abstract

摘要

相似文献

Response to Ryan and Parwani: heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?

Circ Heart Fail. 2012 Nov;5(6):820-1. doi: 10.1161/CIRCHEARTFAILURE.112.972240.

Heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?

Circ Heart Fail. 2012 Nov;5(6):819. doi: 10.1161/CIRCHEARTFAILURE.112.970889.

August 2020 at a glance: focus on neurohormonal antagonists and electrolytes.

Eur J Heart Fail. 2020 Aug;22(8):1289-1290. doi: 10.1002/ejhf.1519.

Neurohormonal antagonism in heart failure: what is the optimal strategy?

Mt Sinai J Med. 2004 Mar;71(2):115-26.

Evidence for the survival benefit of neurohormonal antagonists in the management of geriatric congestive heart failure.

J Okla State Med Assoc. 2003 Mar;96(3):133-9.

Novel neurohormonal antagonist strategies: vasopressin antagonism, anticytokine therapy, and endothelin antagonism in patients who have heart failure.

Heart Fail Clin. 2005 Apr;1(1):103-27. doi: 10.1016/j.hfc.2004.12.002.

[Neurohumoral blocking agents].

Nihon Rinsho. 2011 Nov;69 Suppl 9:394-6.

Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparators.

Int J Cardiol. 2018 Jun 15;261:130-133. doi: 10.1016/j.ijcard.2018.03.034. Epub 2018 Mar 11.

Neurohormonal inhibition in heart failure: insights from recent clinical trials.

Am J Cardiol. 2005 Dec 19;96(12A):3L-9L. doi: 10.1016/j.amjcard.2005.09.059. Epub 2005 Oct 5.

New therapeutics for chronic heart failure.

Annu Rev Med. 2002;53:59-74. doi: 10.1146/annurev.med.53.082901.104004.

引用本文的文献

Ambulatory Care Management in Low Blood Pressure Patient with HFrEF.

Int J Angiol. 2023 Feb 8;34(3):226-232. doi: 10.1055/s-0043-1761271. eCollection 2025 Sep.

PGRMC2 is a pressure-volume regulator critical for myocardial responses to stress in mice.

Nat Commun. 2025 Mar 11;16(1):2422. doi: 10.1038/s41467-025-57707-8.

Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?

Heart Fail Clin. 2024 Oct;20(4):373-386. doi: 10.1016/j.hfc.2024.06.004.

Physicians' Knowledge of the Systematic ABCDE Approach in Riyadh, Saudi Arabia.

J Multidiscip Healthc. 2024 Mar 15;17:1179-1188. doi: 10.2147/JMDH.S451527. eCollection 2024.

Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?

Cardiol Clin. 2023 Nov;41(4):511-524. doi: 10.1016/j.ccl.2023.06.007.

Effect of Lycopene Supplementation on Some Cardiovascular Risk Factors and Markers of Endothelial Function in Iranian Patients with Ischemic Heart Failure: A Randomized Clinical Trial.

Cardiol Res Pract. 2022 Oct 28;2022:2610145. doi: 10.1155/2022/2610145. eCollection 2022.

The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study.

Int J Gen Med. 2021 Oct 12;14:6693-6701. doi: 10.2147/IJGM.S334132. eCollection 2021.

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).

Eur Heart J. 2020 Sep 21;41(36):3402-3418. doi: 10.1093/eurheartj/ehaa496.

Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case-control analyses.

BMJ Open. 2019 Jul 11;9(7):e028750. doi: 10.1136/bmjopen-2018-028750.

Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians.

Am J Cardiovasc Drugs. 2018 Oct;18(5):333-345. doi: 10.1007/s40256-018-0277-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验